IDeAl research spreads overseas

IDeAl senior researcher Nicole Heussen and IDeAl coordinator Ralf-Dieter Hilgers disseminate IDeAl methodology to stakeholders from regulators to academia in the United States. During their three week stay in April 2016, they present their latest results at U.S. Food and Drug Administration (FDA) and give IDeAl input to FDAs guidelines. Furthermore, during their stay, they intensify the collaboration with EAB member W.F. Rosenberger. At George Mason University, Nicole Heussen gives a talk on the treatment of missing values in the randomization test. Ralf-Dieter Hilgers disseminates the latest results on the impact of bias on the test decision given different randomization procedures.